BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17108847)

  • 1. Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women.
    Hofling M; Hirschberg AL; Skoog L; Tani E; Hägerström T; von Schoultz B
    Menopause; 2007; 14(2):183-90. PubMed ID: 17108847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone binding globulin and free testosterone levels--an association with mammographic density.
    Hofling M; Carlström K; Svane G; Azavedo E; Kloosterboer H; Von Schoultz B
    Gynecol Endocrinol; 2005 Feb; 20(2):110-5. PubMed ID: 15823831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast epithelial proliferation in postmenopausal women evaluated through fine-needle-aspiration cytology.
    Conner P; Skoog L; Söderqvist G
    Climacteric; 2001 Mar; 4(1):7-12. PubMed ID: 11379380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone addition during menopausal hormone therapy: effects on mammographic breast density.
    Hofling M; Lundström E; Azavedo E; Svane G; Hirschberg AL; von Schoultz B
    Climacteric; 2007 Apr; 10(2):155-63. PubMed ID: 17453864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction in proliferation with six months of letrozole in women on hormone replacement therapy.
    Fabian CJ; Kimler BF; Zalles CM; Khan QJ; Mayo MS; Phillips TA; Simonsen M; Metheny T; Petroff BK
    Breast Cancer Res Treat; 2007 Nov; 106(1):75-84. PubMed ID: 17221152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone addition to estrogen therapy - effects on inflammatory markers for cardiovascular disease.
    Kocoska-Maras L; Hirschberg AL; Byström B; Schoultz BV; Rådestad AF
    Gynecol Endocrinol; 2009 Dec; 25(12):823-7. PubMed ID: 19906002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between serum testosterone levels, cell proliferation and progesterone receptor content in normal and malignant breast tissue in postmenopausal women.
    Hofling M; Löfgren L; von Schoultz E; Carlström K; Söderqvist G
    Gynecol Endocrinol; 2008 Jul; 24(7):405-10. PubMed ID: 18645713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial.
    Shah S; Bell RJ; Savage G; Goldstat R; Papalia MA; Kulkarni J; Donath S; Davis SR
    Menopause; 2006; 13(4):600-8. PubMed ID: 16837882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutral effect of ultra-low-dose continuous combined estradiol and norethisterone acetate on mammographic breast density.
    Lundström E; Bygdeson M; Svane G; Azavedo E; von Schoultz B
    Climacteric; 2007 Jun; 10(3):249-56. PubMed ID: 17487652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being.
    Flöter A; Nathorst-Böös J; Carlström K; von Schoultz B
    Climacteric; 2002 Dec; 5(4):357-65. PubMed ID: 12626215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aromatase inhibition on sexual function and well-being in postmenopausal women treated with testosterone: a randomized, placebo-controlled trial.
    Davis SR; Goldstat R; Papalia MA; Shah S; Kulkarni J; Donath S; Bell RJ
    Menopause; 2006; 13(1):37-45. PubMed ID: 16607097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgens and the breast.
    von Schoultz B
    Maturitas; 2007 May; 57(1):47-9. PubMed ID: 17386984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testosterone for low libido in postmenopausal women not taking estrogen.
    Davis SR; Moreau M; Kroll R; Bouchard C; Panay N; Gass M; Braunstein GD; Hirschberg AL; Rodenberg C; Pack S; Koch H; Moufarege A; Studd J;
    N Engl J Med; 2008 Nov; 359(19):2005-17. PubMed ID: 18987368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
    Davis SR; Stuckey BG; Norman RJ; Papalia MA; Drillich A; Bell RJ
    Menopause; 2008; 15(6):1065-9. PubMed ID: 18806686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammographic breast density, hormones, and growth factors during continuous combined hormone therapy.
    Conner P; Svane G; Azavedo E; Söderqvist G; Carlström K; Gräser T; Walter F; von Schoultz B
    Fertil Steril; 2004 Jun; 81(6):1617-23. PubMed ID: 15193485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does hormone therapy improve age-related skin changes in postmenopausal women? A randomized, double-blind, double-dummy, placebo-controlled multicenter study assessing the effects of norethindrone acetate and ethinyl estradiol in the improvement of mild to moderate age-related skin changes in postmenopausal women.
    Phillips TJ; Symons J; Menon S;
    J Am Acad Dermatol; 2008 Sep; 59(3):397-404.e3. PubMed ID: 18625536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digitized assessment of mammographic breast density in patients who received low-dose intrauterine levonorgestrel in continuous combination with oral estradiol valerate: a pilot study.
    Lundström E; Söderqvist G; Svane G; Azavedo E; Olovsson M; Skoog L; von Schoultz E; von Schoultz B
    Fertil Steril; 2006 Apr; 85(4):989-95. PubMed ID: 16580385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An isopropanolic extract of black cohosh does not increase mammographic breast density or breast cell proliferation in postmenopausal women.
    Hirschberg AL; Edlund M; Svane G; Azavedo E; Skoog L; von Schoultz B
    Menopause; 2007; 14(1):89-96. PubMed ID: 17019374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG; Leung KC; Sullivan D; Reutens AT; Ho KK
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):690-8. PubMed ID: 14974909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
    Castelo-Branco C; Palacios S; Vázquez F; Villero J; Ferrer J; Ascaso C; Balasch J
    Fertil Steril; 2007 Aug; 88(2):383-9. PubMed ID: 17561009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.